Lara A Pilutti1, Edward McAuley1, Robert W Motl2. 1. Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, 906S. Goodwin Ave., Freer Hall, Urbana, IL 61820, USA. 2. Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, 906S. Goodwin Ave., Freer Hall, Urbana, IL 61820, USA. Electronic address: robmotl@illinois.edu.
Abstract
BACKGROUND: Natural history studies have typically focused on non-modifiable factors as predictors of disability progression in multiple sclerosis (MS). Weight status has emerged as a correlate of disability status in cross-sectional studies of persons with MS and represents a possible modifiable predictor of disability progression over time. OBJECTIVE: This study examined the prospective, bi-directional associations between body mass index (BMI) and disability over a 24-month time course in persons with MS who have mild-to-moderate disability. METHODS: The sample included 269 individuals with relapsing-remitting MS (RRMS) that were part of an ongoing, longitudinal investigation of symptoms and physical activity in persons with RRMS. BMI and PDDS were determined by self-report questionnaires distributed and collected through the U.S. postal service. Data were collected from participants on three occasions: baseline, 12 months, and 24 months. RESULTS: Mean BMI at baseline was 27.2 (7.0)kg/m(2) and over 50% of participants were classified as overweight (BMI=25.0-29.9kg/m(2)) or obese (BMI≥30.0kg/m(2)). There was a significant increase in PDDS over the study period (p<0.0001), but no change in BMI (p=0.41). There were no significant correlations between BMI and PDDS for any of the three time points (p>0.05). Path analysis indicated a minimal and inconsistent impact of BMI on the change in PDDS over time, and PDDS had a minimal and inconsistent influence on change in BMI. CONCLUSIONS: Over a 24-month time course, we demonstrated an increase in disability, but minimal evidence that this change was predicted by BMI in persons with mild-to-moderate MS. Even though BMI was not predictive of disability, the prevalence of overweight and obesity was considerable and should be the focus of subsequent intervention in MS.
BACKGROUND: Natural history studies have typically focused on non-modifiable factors as predictors of disability progression in multiple sclerosis (MS). Weight status has emerged as a correlate of disability status in cross-sectional studies of persons with MS and represents a possible modifiable predictor of disability progression over time. OBJECTIVE: This study examined the prospective, bi-directional associations between body mass index (BMI) and disability over a 24-month time course in persons with MS who have mild-to-moderate disability. METHODS: The sample included 269 individuals with relapsing-remitting MS (RRMS) that were part of an ongoing, longitudinal investigation of symptoms and physical activity in persons with RRMS. BMI and PDDS were determined by self-report questionnaires distributed and collected through the U.S. postal service. Data were collected from participants on three occasions: baseline, 12 months, and 24 months. RESULTS: Mean BMI at baseline was 27.2 (7.0)kg/m(2) and over 50% of participants were classified as overweight (BMI=25.0-29.9kg/m(2)) or obese (BMI≥30.0kg/m(2)). There was a significant increase in PDDS over the study period (p<0.0001), but no change in BMI (p=0.41). There were no significant correlations between BMI and PDDS for any of the three time points (p>0.05). Path analysis indicated a minimal and inconsistent impact of BMI on the change in PDDS over time, and PDDS had a minimal and inconsistent influence on change in BMI. CONCLUSIONS: Over a 24-month time course, we demonstrated an increase in disability, but minimal evidence that this change was predicted by BMI in persons with mild-to-moderate MS. Even though BMI was not predictive of disability, the prevalence of overweight and obesity was considerable and should be the focus of subsequent intervention in MS.
Authors: Emmanuelle Waubant; Robyn Lucas; Ellen Mowry; Jennifer Graves; Tomas Olsson; Lars Alfredsson; Annette Langer-Gould Journal: Ann Clin Transl Neurol Date: 2019-08-07 Impact factor: 4.511
Authors: Claudia Helena Marck; Sandra Leanne Neate; Keryn Louise Taylor; Tracey Joy Weiland; George Alexander Jelinek Journal: PLoS One Date: 2016-02-05 Impact factor: 3.240
Authors: Ali Manouchehrinia; Anna Karin Hedström; Lars Alfredsson; Tomas Olsson; Jan Hillert; Ryan Ramanujam Journal: Front Neurol Date: 2018-05-11 Impact factor: 4.003